Veratrak, a London-based startup that aims to digitise the pharmaceutical supply chain, has picked up £1 million in seed funding. Leading the round is Force Over Mass, with participation from Seedcamp, Ascension Ventures, Blockchain Valley Ventures, and Truesight Ventures.
A number of individual investors have also backed the young company. They include ex-Head of Corporate Strategy for Microsoft, Charlie Songhurst, current EVP of Operations at Vectura Group and previous Vice President of Global Supply Chain at Baxter, Tony Fitzpatrick, and Antonin de Fougerolles, CEO of Evox Therapeutics.
Launched in August 2018, Veratrak offers a “document collaboration and workflow management platform” targeting the pharmaceutical industry. The SaaS enables organisations to on-board both internal and external partners to verify, authenticate, review, and sign-off on “critical documentation” related